PE Ratio:
108.77+2.48(+2.33%)Summary
- As of today, PTGX price to earnings ratio is 108.77, with a rise of +2.48 (+2.33%) during the most recent trading session on October 17, 2025.
- Over the past year, PTGX PE ratio has increased by +91.13 (+516.61%).
- PTGX PE ratio is now -10.92% below its all-time high of 122.11.
Performance
PTGX PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
PE Ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
PTGX PE Ratio Trends
| PeriodPeriod | PE RatioPE Ratio | PricePrice | TTM EPSTTM EPS | TTM RevenueTTM Revenue |
|---|---|---|---|---|
| 1D1 Day | +2.3% | +2.3% | -6.3% | +0.7% |
| 1M1 Month | +30.9% | +30.9% | - | - |
| 3M3 Months | +37.3% | +37.3% | -6.3% | +0.7% |
| 6M6 Months | +78.8% | +67.5% | - | - |
| YTDYTD | +1084.9% | +100.8% | - | - |
| 1Y1 Year | +516.6% | +64.8% | -72.9% | -34.5% |
| 5Y5 Years | - | +272.2% | +133.0% | +714.0% |
PTGX PE Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 122.11 | -10.9% | 83.12 | +30.9% |
| 3M | 3-Month | 122.11 | -10.9% | 71.52 | +52.1% |
| 6M | 6-Month | 122.11 | -10.9% | 55.23 | +96.9% |
| 1Y | 1-Year | 122.11 | -10.9% | 8.34 | +1204.2% |
| 3Y | 3-Year | 122.11 | -10.9% | 8.34 | +1204.2% |
| 5Y | 5-Year | 122.11 | -10.9% | 8.34 | +1204.2% |
| All-Time | All-Time | 122.11 | -10.9% | 8.34 | +1204.2% |
PTGX PE Ratio History
| Date | Value |
|---|---|
| 2025 | 108.77(+1084.9%) |
| Date | Value |
|---|---|
| 2024 | 9.18 |
FAQ
- What is Protagonist Therapeutics, Inc. price to earnings ratio?
- What is the all-time high PE ratio for Protagonist Therapeutics, Inc.?
- What is PTGX price to earnings ratio year-to-date change?
- What is Protagonist Therapeutics, Inc. PE ratio year-on-year change?
What is Protagonist Therapeutics, Inc. price to earnings ratio?
The current PE ratio of PTGX is 108.77
What is the all-time high PE ratio for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high price to earnings ratio is 122.11
What is PTGX price to earnings ratio year-to-date change?
Protagonist Therapeutics, Inc. price to earnings ratio has changed by +99.59 (+1084.86%) since the beginning of the year
What is Protagonist Therapeutics, Inc. PE ratio year-on-year change?
Over the past year, PTGX price to earnings ratio has changed by +91.13 (+516.61%)